Ma SJ, Yu H, Khan M, Yu B, et al. Defining the optimal threshold and prognostic utility of pre-treatment hemoglobin level as a biomarker for survival outcomes in head and neck cancer patients receiving chemoradiation. Oral Oncol 2022;133:106054.
PMID: 35933937